4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0000899243-18-019736
Chief Medical Officer sold 1,760 shares at an average $15.01 ($26,415)
- Chief Medical Officer acquired 1,760 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
FINCK BARBARA K · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-07-09 | Exercise or conversion : show line 1 in the form | +500 | $1.42 | $710 | 37,543 | D |
| 2018-07-09 | Sale : show line 2 in the form | −500 | $15.03 | $7,515 | 37,043 | D |
| 2018-07-10 | Exercise or conversion : show line 3 in the form | +1,260 | $1.42 | $1,789 | 38,303 | D |
| 2018-07-10 | Sale : show line 4 in the form | −1,260 | $15.00 | $18,900 | 37,043 | D |
| Open-market sales · 1,760 sh · avg $15.01 · $26,415 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-07-09 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −500 | 87,721 | D |
| 2018-07-10 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −1,260 | 86,461 | D |
Loading xslF345X03/doc4.xml…